Skip to main content
Clinical Trials/IRCT2015112325208N1
IRCT2015112325208N1CompletedPhase 4

The effect of preoperative intravenous tranexamic acid on hemorrhage in patients who undergoing cleft palate reconstraction surgery

Vice Chancellor for research of Zahedan University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 year to 12 years (—)
Sex
All

Inclusion Criteria

  • Inclusion Criteria: Palatoplasty indication in patients with presence of congenital cleft palate (with or without associated cleft lip).

Exclusion Criteria

  • Preoperative hemoglobin lower than 10 mg/dl or platelet count less than 100,000/mm3;
  • Presence of coagulopathy caused by known coagulation cascade disorders or systemic diseases, or excessive bleeding history on previous occasions;
  • History of bleeding disorders in first-degree relatives;
  • Use of medications that may interfere with the coagulation cascade (platelet inhibitors or anticoagulants);
  • Indication of secondary palatoplasty with the purpose of correction oro-nasal fistula;
  • Known allergy to tranexamic acid;
  • History of hematuria.

Investigators

Sponsor
Vice Chancellor for research of Zahedan University of Medical Sciences

Similar Trials

The effect tranexamic acid on hemorrhage... | Clinical Trial